semaglutide and oral birth control & Control: Safety, Interactions & Guidance – PlexusDx Semaglutide, a Once-Weekly Human GLP-1

Whilst laboratory research suggests potential immunomodulatory properties, robust randomised controlled trials in humans are lacking, and no clinical recommendations can currently be made

This GH release encourages fat metabolism, lean muscle growth, and tissue repair while minimizing the risk of side effects commonly associated with GH stimulation, such as elevated cortisol levels

Patho 101: GLP-1 receptors are found in areas of the brain involved in appetite regulation, such as the hypothalamus, and activation of these receptors can lead to decreased food intake and increased feelings of fullness

WakeMed Clinical Pharmacist Janna Beavers offers the following guidance for evaluating GLP-1 treatment for any indication

Phase 2 data, whilst promising, does not constitute sufficient evidence for clinical use outside of a research context

The New York Times (2024)